C81.40
BillableLymphocyte-rich Hodgkin lymphoma, unspecified site
HCC Category Mapping
V28HCC 21 — Breast, Prostate, Colorectal and Other Cancers and Tumors
0.545V24HCC 10 — Lymphoma and Other Cancers
0.675ESRDHCC 10 — Lymphoma and Other Cancers
0.000RxHCCHCC 21 — Hodgkin Lymphoma and Other Cancers
0.000What This Code Means
A rare type of Hodgkin lymphoma (lymphocyte-rich variant) with an unspecified location of involvement.
Coding Tips
- •Use this code only when the specific site of lymphoma involvement is not documented
- •Query the provider if site information is available to assign a more specific code
Clinical Significance
Lymphocyte-rich Hodgkin lymphoma is a relatively uncommon subtype of classical Hodgkin lymphoma with the most favorable prognosis among all Hodgkin subtypes, often presenting at an early stage. The unspecified site designation means the anatomic location was not documented. Despite its indolent behavior, these patients require ongoing monitoring and treatment, and the code is important for risk adjustment capture.
Documentation Requirements
- ✓Pathology confirming lymphocyte-rich classical Hodgkin lymphoma (distinct from nodular lymphocyte predominant Hodgkin lymphoma, which is classified separately)
- ✓Query provider for anatomic site when available to use a more specific code
- ✓Ann Arbor staging documentation
- ✓Treatment status: active therapy, watch-and-wait, or surveillance
- ✓Provider assessment during the encounter
Commonly Confused Codes
C81.30 — Lymphocyte depleted Hodgkin lymphoma, unspecified: opposite histologic pattern with vastly different prognosis; pathology distinction is criticalC81.00 — Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site: this is a SEPARATE entity from lymphocyte-rich classical Hodgkin lymphoma with different biology and treatmentC81.90 — Hodgkin lymphoma, unspecified type: use C81.40 when the subtype is confirmed as lymphocyte-rich even if the site is not documented